Chen et al. reported that proton pump inhibitors inhibited the V-ATPase/PI3K/AKT/mTOR/HIF-1 alpha signaling pathways and downregulated TSC1/2 and Rheb expression in gastric cancer cells to reverse multidrug resistance [49]. Here, MTOR is linked to gastric cancer.